| Trusted Hospice Care, Inc 1811 East Center Street, Suite 202, Anaheim, CA, 92805 | |
| (714) 817-6948 |
News Archive
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and the Regenstrief Institute Inc. to study ways to improve health care access for the underinsured.
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
› Verified 3 days ago
| Name | Trusted Hospice Care, Inc |
|---|---|
| Location | 1811 East Center Street, Suite 202, Anaheim, California |
| Hospice ID | 751669 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 400 |
News Archive
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and the Regenstrief Institute Inc. to study ways to improve health care access for the underinsured.
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and the Regenstrief Institute Inc. to study ways to improve health care access for the underinsured.
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
› Verified 3 days ago
| Home Health Aides | 1 |
| Counselors | 3 |
| Homemakers | 1 |
| Licensed Practical or Vocational Nurses | 0.5 |
| Medical Social Workers | 2 |
| Physicians | 1 |
| Registered Nurses | 1 |
| Other Personnel | 9.5 |
| Total Employees | 19 |
|---|
News Archive
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and the Regenstrief Institute Inc. to study ways to improve health care access for the underinsured.
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
› Verified 3 days ago
| Counselors | 5 |
| Others | 5 |
| Total Volunteers | 10 |
|---|
News Archive
"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."
MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.
The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and the Regenstrief Institute Inc. to study ways to improve health care access for the underinsured.
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
› Verified 3 days ago
| St Joseph Health Sys Home Care Services - Hospice Location: 200 W Center Street Promenade, Suite 200b, Anaheim, California, 92805 Phone: (714) 817-6948 |
| Compassus Hospice Anaheim Location: 505 N Euclid St, Suite 480, Anaheim, California, 92801 Phone: (714) 817-6948 |
| Sunrise Hospice Care Corporation Location: 970 N Tustin Ave, Suite 101, Anaheim, California, 92807 Phone: (714) 817-6948 |
| New Haven Hospice Care, Inc Location: 1700 E Lincoln Avenue, Suite 202, Anaheim, California, 92805 Phone: (714) 817-6948 |